Incidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population

Diabetes Mellitus type 2 (T2DM) is one of the most frequent metabolic diseases worldwide. It is expected that in 2035 around 600 million people will suffer from the disease. A recent systematic review has estimated that the direct annual cost of Diabetes worldwide treatments and care is over $ 827 billion and has been independently associated with nosocomial complications, thrombosis-like infections and prolonged admissions. In addition, it is estimated that up to 90% of patients in acute hospitals require a peripheral venous catheter which are associated at the same time with mechanical, infectious and thrombotic acute complications. Recently the emergence of new medium-sized peripheral devices (Midline®) and new peripheral central venous access catheters (PICC), which are more biocompatible, are opening new clinical possibilities with the aim of improving safety and comfort during treatment time and the reduction of associated complications.

With all this, an observational case-control study has been proposed in order to analyse the impact of T2DM disease and its associated complications on the patient requiring peripheral venous access. Furthermore investigators will consider if these new peripheral devices can be a remarkable benefit for these patients. This study will be carried out at the Vall d'Hebron University Hospital in Barcelona, Spain

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Cardiovascular Diseases Catheter-Related Infections Catheterization, Peripheral Diabetes Complications Diabetes Mellitus Embolism and Thrombosis Endocrine System Diseases Glucose Metabolism Disorders Infections Metabolic Diseases Nutritional and Metabolic Diseases Thrombosis Upper Extremity Deep Vein Thrombosis Vascular Diseases Venous Thrombosis

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Vall d'Hebron Research Institute-VHIR

Barcelona, 08035, Spain

About this study

This Prospective case-control study will be carried out with patients that will be admitted in the hospitalization areas of the Vall d'Hebron Hospital. All research data will be collected by the hospital's vascular access nursing team. Complications related to peripheral venous access (phlebitis, thrombosis, pain, erythema, extravasation) and the time of catheter replacement are the focus outcomes of the present study and possible differences between the control group and the sample population of the T2DM will be analysed. General clinical and anthropometric data (age, sex, BMI, toxic habits,...), cause of admission, co-morbidities, and all variables related to diabetes (time of evolution, degree of glycemic control, treatment, and presence of chronic complications) will also be collected. If there are any significant differences, they will be related to the different risk factors associated with T2DM through association of different epidemiological variables. Furthermore in this hypothetical case, the research team would intend to develop and carry out molecular studies through analysis of blood and urine components, proteinomics and genetic studies.

Hypothesis:

T2DM is an independent risk factor for catheter-related complications.
The use of new vascular access devices (Midline, PICC) in patients with T2DM would be associated with a lower risk of catheter-related complications.

Main objective:

To assess the influence of T2DM on complications related to peripheral vascular catheters in hospitalized patients.

It is expected to colect information of N=500 samples, 250 control group (noT2DM subjects) and 250 study group (T2DM subjects). Due to previous experience, the sample proposed is totally acceptable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Peripheral venous access requirement >7 days
Administration of intravenous treatment

Exclusion criteria

Peripheral venous access for urgent or life-threatening pathology
Acute psychiatric pathology
Impossibility of peripheral venous access through the upper limb (amputations, extensive burns, etc.)
History of venous thrombosis due to catheter less than 1 year

Treatment and study plan

Peripheral vascular catheters

Device

Carry time of common peripheral vascular devices in clinical practice and the reason for his withdrawal

Other names: Short canula, Midline, PICC

Primary outcomes

How is the influence of T2DM on complications related to peripheral vascular catheters in hospitalized patients

Time frame: 12 month

Rate of complications associated with catheters: thrombosis, infection, pain and skin reaction

Sponsors and collaborators

Lead sponsor

Hospital Universitari Vall d'Hebron Research Institute

Other

Registry information

Official study title

Incidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population. Analysis of Risk Factors and Comparative Study of Two Peripheral Devices

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Aug 5, 2020
Registry last updated: Feb 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed